Dosimetric considerations for patients with HIP prostheses undergoing pelvic irradiation. Report of the AAPM Radiation Therapy Committee Task Group 63

This document is the report of a task group of the Radiation Therapy Committee of the AAPM and has been prepared primarily to advise hospital physicists involved in external beam treatment of patients with pelvic malignancies who have high atomic number (Z) hip prostheses. The purpose of the report is to make the radiation oncology community aware of the problems arising from the presence of these devices in the radiation beam, to quantify the dose perturbations they cause, and, finally, to provide recommendations for treatment planning and delivery. Some of the data and recommendations are also applicable to patients having implanted high-Z prosthetic devices such as pins, humeral head replacements. The scientific understanding and methodology of clinical dosimetry for these situations is still incomplete. This report is intended to reflect the current state of scientific understanding and technical methodology in clinical dosimetry for radiation oncology patients with high-Z hip prostheses.

Single dose versus fractionated stereotactic radiotherapy for recurrent high-grade gliomas

PURPOSE

To evaluate the efficacy of stereotactic radiotherapy (SRT) in patients with recurrent high-grade gliomas by comparing two different treatment regimens, single dose or fractionated radiotherapy.

METHODS AND MATERIALS

Between April 1991 and January 1998, 71 patients with recurrent high-grade gliomas were treated with SRT. Forty-six patients (65%) were treated with single dose radiosurgery (SRS) and 25 patients (35 %) with fractionated stereotactic radiotherapy (FSRT). For the SRS group, the median radiosurgical dose of 17 Gy was delivered to the median of 50% isodose surface (IDS) encompassing the target. For the FSRT group, the median dose of 37.5 Gy in 15 fractions was delivered to the median of 85% IDS.

RESULTS

Actuarial median survival time was 11 months for the SRS group and 12 months for the FSRT group (p = 0.3, log-rank test). Variables predicting longer survival were younger age (p = 0.006), lower grade (p = 0.0006), higher Karnofsky Performance Scale (KPS) (p = 0.0005), and smaller tumor volume (p = 0.02). Patients in the SRS group had more favorable prognostic factors, with median age of 48 years, KPS of 70, and tumor volume of 10 ml versus median age of 53 years, KPS of 60, and tumor volume of 25 ml in the FSRT group. Late complications developed in 14 patients in the SRS group and 2 patients in the FSRT group (p<0.05).

CONCLUSION

Given that FSRT patients had comparable survival to SRS patients, despite having poorer pretreatment prognostic factors and a lower risk of late complications, FSRT may be a better option for patients with larger tumors or tumors in eloquent structures. Since this is a nonrandomized study, further investigation is needed to confirm this and to determine an optimal dose/fractionation scheme.

Measurement of dose in the buildup region using fixed-separation plane-parallel ionization chambers

Accurate measurement of dose at the surface of a phantom and in the buildup region is a difficult task but one that is important for the proper treatment of patients. The instruments of choice for these measurements are extrapolation chambers but few institutions have these instruments at their disposal. As a result, fixed-separation plane-parallel ionization chambers are most commonly used for this purpose. Recent papers have re-emphasized the inaccuracies in the measurement of dose in the buildup region of normally incident photon beams when using fixed-separation plane-parallel ionization chambers. Data for Co-60, 6-, 10-, 18-, and 24-MV photon beams are presented that show the magnitude of this over response in the buildup region for several commercially available plane-parallel ionization chambers versus results obtained using both an extrapolation chamber and LiF thermoluminescent detectors. Differences in the percent depth dose at the surface of a phantom of greater than 19% were found for one of the chambers. All chambers over responded in the buildup region to some degree based upon their internal dimensions. The appropriateness of published corrections for these chambers is evaluated and guidelines for the accurate measurement of dose in the buildup region are presented.

Stereotactic radiosurgery for recurrent malignant gliomas

PURPOSE

To evaluate the role of stereotactic radiosurgery in the management of recurrent malignant gliomas.

PATIENTS AND METHODS

We treated 35 patients with large (median treatment volume, 28 cm3) recurrent tumors that had failed to respond to conventional treatment. Twenty-six patients (74%) had glioblastomas multiforme (GBM) and nine (26%) had anaplastic astrocytomas (AA).

RESULTS

The mean time from diagnosis to radiosurgery was 10 months (range, 1 to 36), from radiosurgery to death, 8.0 months (range, 1 to 23). Twenty-one GBM (81%) and six AA (67%) patients have died. The actuarial survival time for all patients was 21 months from diagnosis and 8 months from radiosurgery. Twenty-two of 26 patients (85%) died of local or marginal failure, three (12%) of noncontiguous failure, and one (4%) of CSF dissemination. Age (P = .0405) was associated with improved survival on multivariate analysis, and age (P = .0110) and Karnofsky performance status (KPS) (P = .0285) on univariate analysis. Histology, treatment volume, and treatment dose were not significant variables by univariate analysis. Seven patients required surgical resection for increasing mass effect a mean of 4.0 months after radiosurgery, for an actuarial reoperation rate of 31%. Surgery did not significantly influence survival. At surgery, four patients had recurrent tumor, two had radiation necrosis, and one had both tumor and necrosis. The actuarial necrosis rate was 14% and the pathologic findings could have been predicted by the integrated logistic formula for developing symptomatic brain injury.

CONCLUSION

Stereotactic radiosurgery appears to prolong survival for recurrent malignant gliomas and has a lower reoperative rate for symptomatic necrosis than does brachytherapy. Patterns of failure are similar for both of these techniques.

Recommendations for clinical electron beam dosimetry: supplement to the recommendations of Task Group 25

The goal of Task Group 25 (TG-25) of the Radiation Therapy Committee of the American Association of.Physicists in Medicine (AAPM) was to provide a methodology and set of procedures for a medical physicist performing clinical electron beam dosimetry in the nominal energy range of 5-25 MeV. Specifically, the task group recommended procedures for acquiring basic information required for acceptance testing and treatment planning of new accelerators with therapeutic electron beams. Since the publication of the TG-25 report, significant advances have taken place in the field of electron beam dosimetry, the most significant being that primary standards laboratories around the world have shifted from calibration standards based on exposure or air kerma to standards based on absorbed dose to water. The AAPM has published a new calibration protocol, TG-51, for the calibration of high-energy photon and electron beams. The formalism and dosimetry procedures recommended in this protocol are based on the absorbed dose to water calibration coefficient of an ionization chamber at 60Co energy, N60Co(D,w), together with the theoretical beam quality conversion coefficient k(Q) for the determination of absorbed dose to water in high-energy photon and electron beams. Task Group 70 was charged to reassess and update the recommendations in TG-25 to bring them into alignment with report TG-51 and to recommend new methodologies and procedures that would allow the practicing medical physicist to initiate and continue a high quality program in clinical electron beam dosimetry. This TG-70 report is a supplement to the TG-25 report and enhances the TG-25 report by including new topics and topics that were not covered in depth in the TG-25 report. These topics include procedures for obtaining data to commission a treatment planning computer, determining dose in irregularly shaped electron fields, and commissioning of sophisticated special procedures using high-energy electron beams. The use of radiochromic film for electrons is addressed, and radiographic film that is no longer available has been replaced by film that is available. Realistic stopping-power data are incorporated when appropriate along with enhanced tables of electron fluence data. A larger list of clinical applications of electron beams is included in the full TG-70 report available at http://www.aapm.org/pubs/reports. Descriptions of the techniques in the clinical sections are not exhaustive but do describe key elements of the procedures and how to initiate these programs in the clinic. There have been no major changes since the TG-25 report relating to flatness and symmetry, surface dose, use of thermoluminescent dosimeters or diodes, virtual source position designation, air gap corrections, oblique incidence, or corrections for inhomogeneities. Thus these topics are not addressed in the TG-70 report.

Patient selection criteria for the treatment of brain metastases with stereotactic radiosurgery

In this study we evaluate prognostic factors that predict local-regional control and survival following stereotactic radiosurgery (SRS) in patients with brain metastasis and establish guidelines for patient selection. Our evaluation is based on 73 patients with brain metastasis treated with SRS at the University of Minnesota between March 1991 and November 1995. The ability of stereotactic radiosurgery to improve local control in patients with brain metastases is confirmed in our study in which only 6 of 62 patients failed locally after SRS, with an actuarial local progression-free survival of 80% at 2 years. Variables that predicted worse prognosis were larger tumor size (p = 0.05) for local progression-free survival and multiplicity of metastasis (p = 0.03) and infratentorial location of metastases (p = 0.006) for regional progression-free survival. Absence of extracranial disease, KPS > or = 70, and single intracranial metastasis were significant predictors of longer survival. Patients who fulfill all three criteria will survive longer after SRS (MS = 17.7 months) and will most likely benefit from the increase local control in the brain achieved by SRS. Survival in patients who do not meet any of these criteria is very poor (MS = 1.5 months), and these patients are less likely to benefit from this treatment. Careful selection of patients for SRS is warranted.

Dosimetry of asymmetric x-ray collimators

We have studied the dosimetry of an independent jaw system (provided with the Varian Clinac 2,500) using ionometric measurements performed both in air and in a water phantom. Our study shows that the effect of the independent jaw on the dose distribution is similar to that of secondary blocking except for changes produced in the collimator scatter. A system of dose calculation was developed which takes into account the changes in the collimator scatter as well as in the isodose distribution. A method is described to correctly generate isodose curves for fields shaped by an independent jaw using a modified AECL TP11 treatment planning system. The primary modification in the program consists of correcting the zero-area tissue-maximum ratios for the off-axis variation in beam quality.

The polarity effect for commercially available plane-parallel ionization chambers

The polarity effect was investigated for three different commercially available plane-parallel ionization chambers: the Memorial Pipe chamber, the Victoreen/Nuclear Associates model 30-329 chamber manufactured by PTW, Frieburg, and the Capintec PS-033 thin-window ionization chamber. The primary study was the polarity effect versus depth below the phantom surface for 6-, 10-, 18-, and 24-MV x-ray beams, and 9- and 22-MeV electron beams. The polarity effect in the region of nonelectronic equilibrium that exists at the interface of two dissimilar materials, polystyrene and aluminum, was investigated as well as the effects of field size. For the group of plane-parallel ionization chambers that we studied, we found a polarity effect of only 1%-2% for electron beams at the depth of dmax. At depths greater than dmax, the polarity effect for electrons increased and was as high as 4.5% for some chambers. When used in the buildup region of high-energy photon beams, these same chambers exhibited up to a 30% difference in collected charge between one polarity and the other. This effect and its relationship to physical chamber characteristics is discussed.

Evaluation of dose variation during total skin electron irradiation using thermoluminescent dosimeters

PURPOSE

To determine acceptable dose variation using thermoluminescent dosimeters (TLD) in the treatment of Mycosis Fungoides with total skin electron beam (TSEB) irradiation.

METHODS AND MATERIALS

From 1983 to 1993, 22 patients were treated with total skin electron beam therapy in the standing position. A six-field technique was used to deliver 2 Gy in two days, treating 4 days per week, to a total dose of 35 to 40 Gy using a degraded 9 MeV electron beam. Thermoluminescent dosimeters were placed on several locations of the body and the results recorded. The variations in these readings were analyzed to determine normal dose variation for various body locations during TSEB.

RESULTS

The dose to flat surfaces of the body was essentially the same as the dose to the prescription point. The dose to tangential surfaces was within +/- 10% of the prescription dose, but the readings showed much more variation (up to 24%). Thin areas of the body showed large deviations from the prescription dose along with a large amount of variation in the readings (up to 22%). Special areas of the body, such as the perineum and eyelid, showed large deviations from the prescription dose with very large (up to 40%) variations in the readings.

DISCUSSION

The TLD results of this study will be used as a quality assurance check for all new patients treated with TSEB. The results of the TLDs will be compared with this baseline study to determine if the delivered dose is within acceptable ranges. If the TLD results fall outside the acceptable limits established above, then the patient position can be modified or the technique itself evaluated.

In vivodiode dosimetry for routine quality assurance in IMRT

Due to the complexity of IMRT dosimetry, dose delivery evaluation is generally done using a treatment plan in which the optimized fluence distribution has been transferred to a test phantom for accessibility and simplicity of measurement. The actual patient doses may be reconstructed in vivo through the use of electronic portal imaging devices or films, but the assessment of absolute dose from these measurements is time-consuming and complicated. In our clinic we have instituted the use of routine diode dosimetry for IMRT patients following the same procedure used for standard radiation therapy patients in which each new treatment field is checked at the start of treatment. For standard cases the dose at dmax is calculated as part of the monitor unit calculation. For the IMRT cases, the dose contribution to the dmax depth for each field is taken from the treatment plan. We found that about 90% of the diode measurements agreed to within +/- 10% of the planned doses (45/51 fields) and 63% (32/51 fields) achieved +/- 5% agreement. By using this direct in vivo method to verify the clinical doses delivered, we have been able to make a uniform startup procedure for all patients while simplifying our IMRT QA process.

Radiation Treatment Decreases Bone Cancer Pain, Osteolysis and Tumor Size

Radiotherapy is the cornerstone of palliative treatment for primary bone cancer in animals and metastatic bone cancer in humans. However, the mechanism(s) responsible for pain relief after irradiation is unknown. To identify the mechanism through which radiation treatment decreases bone cancer pain, the effect of radiation on mice with painful bone cancer was studied. Analysis of the effects of a 20-Gy treatment on localized sites of painful bone cancers was performed through assessments of animal behavior, radiographs and histological analysis. The findings indicated that radiation treatment reduced bone pain and supported reduced cancer burden and reduced osteolysis as mechanisms through which radiation reduces bone cancer pain.

Calculation of depth dose and dose per monitor unit for irregularly shaped electron fields

A new dosimetric quantity, the lateral build-up ratio (LBR), has been introduced to calculate depth dose distribution for any shaped field. Factors to account for change in incident fluence with collimation are applied separately. The LBR data for a small circular field are used to extract radial spread of the pencil beam, sigma(r), as a function of depth and energy. By using the relationship between LBR, sigma(r), energy and depth, a formalism is developed to calculate dose per monitor unit for any shaped field. Criteria for lateral scatter equilibrium are also developed which are useful in clinical dosimetry.

Single dose versus fractionated stereotactic radiotherapy for meningiomas

OBJECTIVE

To evaluate the safety and efficacy of stereotactic radiosurgery (SRS) compared to fractionated stereotactic radiation therapy (FSRT) for meningiomas treated over a seven year period.

METHODS AND MATERIALS

Of the 53 patients (15 male and 38 female) with 63 meningiomas, 35 were treated with SRS and the 18 patients with tumors adjacent to critical structures or with large tumors were treated with FSRT. The median doses for the SRS and the FSRT groups were 1400 cGy (500-4500 cGy) and 5400 cGy (4000-6000 cGy) respectively. Median target volumes for SRS and FSRT were 6.8 ml and 8.8 ml respectively. The median follow-up for the SRS and FSRT groups were 38 months (4.1-97 months) and 30.5 months (6.0-63 months) respectively.

RESULTS

The five-year tumor control probability (TC) for benign versus atypical meningiomas were 92.7% vs. 31% (P = .006). The three-year TC were 92.7% vs. 93.3% for SRS vs. FSRT groups respectively (P = .62). For benign meningiomas, the three-year TC were 92.9% vs. 92.3% for the SRS group (29 patients) vs. FSRT group (14 patients) respectively (P = .77). Two patients in the SRS group and one in the FSRT group developed late complications.

CONCLUSION

Preliminary data suggest that SRS is a safe and effective treatment for patients with benign meningiomas. Fractionated stereotactic radiation therapy with conventional fractionation appeared to be an effective and safe treatment alternative for patients not appropriate for SRS. A longer follow-up is required to determine the long-term efficacy and the toxicity of these treatment modalities.

Evaluation of a model-based treatment planning system for dose computations in the kilovoltage energy range

The ability to determine dose distribution and calculate organ doses from diagnostic x rays has become increasingly important in recent years because of relatively high doses in interventional radiology and cardiology procedures. In an attempt to determine the dose from both diagnostic and orthovoltage x rays, we have used a commercial treatment planning system (Pinnacle, ADAC Laboratories, Milpitas, CA) to calculate the doses in phantoms from kilovoltage x rays. The planning system's capabilities for dose computation have been extended to lower energies by the addition of energy deposition kernels in the 20-110 keV range and modeling of the 60, 80, 100, and 120 kVp beams using the system. We compared the dose calculated by the system with that measured using thermoluminescent dosimeters (TLDs) placed in various positions within several phantoms. The phantoms consisted of a cubical solid water phantom, the solid water phantom with added lung and bone inhomogeneities, and the Rando anthropomorphic phantom. Using Pinnacle, a treatment plan was generated using CT scans of each of these phantoms and point doses at the positions of TLD chips were calculated. Comparisons of measured and computed values show an average difference of less than 2% within materials of atomic number less than and equal to that of water. The algorithm, however, does not produce accurate results in and around bone inhomogeneities and underestimates attenuation of x rays by bone by an average of 145%. A modification to the CT number-to-density conversion table used by the system resulted in significant improvements in the dose calculated to points beyond bone.

The response characteristics of a newly designed plane-parallel ionization chamber in high-energy photon and electron beams

A new plane-parallel ionization chamber has been designed by Attix to overcome the shortcoming of previous commercially available parallel-plate ionization chambers for dosimetry in high-energy photon and electron beams in radiation oncology. This investigation details the performance characteristics of this new, commercially available plane-parallel chamber. The magnitude of the polarity effect in high-energy electron beams is shown to be less than 1% while the polarity effect in high-energy photon beams is lower than several other plane-parallel ionization chambers. The over response of the chamber in the buildup region of normally incident high-energy photon beams is less than 1% for 6- and 24-MV x rays while the response of the new chamber to obliquely incident x-ray beams was affected much less by the angle of beam incidence than the other chambers tested. These superior response characteristics are primarily due to the construction characteristics of the collecting electrode arrangement. The Attix chamber, with a wall diameter (w) of 40 mm and a plate separation (s) of 1 mm, has an aspect ratio, (w/s), of 40. This exceeds the previously reported design criterion of w/s > or = 25 required to properly measure surface and buildup dose in either conventional therapy beams or in beams that are highly contaminated.

Generation and use of photon energy deposition kernels for diagnostic quality x rays

Accurately determining the dose from low energy x rays is becoming increasingly important. This is especially so because of high doses in interventional radiology procedures and also because of the desire to model accurately the dose around low energy brachytherapy sources. Various methods to estimate the dose from specific procedures are available but they only give a general idea of the true dose to various organs. The use of sophisticated three-dimensional (3D) dose deposition algorithms designed originally for radiation therapy treatment planning can be extended to lower photon energy regions. The majority of modern 3D treatment planning systems use a variation of the convolution algorithm to calculate dose distributions. This could be extended into the diagnostic energy range with the availability of lower energy deposition kernels ( < 100 keV). We have used version four of the Electron Gamma Shower (EGS4) system of Monte Carlo codes to generate photon energy deposition kernels in the energy range of 20-110 keV and have implemented them in a commercial 3D treatment planning system (Pinnacle, ADAC Laboratories, Milpitas, CA). The kernels were generated using the "SCASPH" EGS4 user code by selecting the appropriate transport parameters suitable for the relative low energy of the incident photons. The planning system was subsequently used to model diagnostic quality beams and to calculate depth dose and cross profile curves. Comparisons of the calculated curves have been made with measurements performed in a homogeneous water phantom.

Dose buildup for obliquely incident photon beams

For obliquely incident photon beams, the buildup of dose with depth is markedly different from normally incident beams. However, relatively little data on this topic exists for high-energy photon beams of energy greater than 6 MV. Measurements of dose in the buildup region were made using a plane-parallel ionization chamber in a polystyrene phantom with obliquely incident 6-, 10-, 18-, and 24-MV x-ray beams angled 0 degrees to 84 degrees. Buildup curves at these angles were plotted and from these an obliquity factor, defined as the ratio of ionization charge collected at a point for a particular angle of incidence to that collected at the same point at normal incidence, was determined. For each energy, the obliquity factor as a function of depth, field size, and source-chamber distance was studied. Results indicate that the obliquity factor is highly dependent on the beam energy, angle of incidence, the collimator opening, and the source-skin distance. A mathematical expression has been developed to predict the dose in the buildup region of high-energy photon beams for various angles of beam incidence, field size, and chamber distance.

Geometrical accuracy of a 3-tesla magnetic resonance imaging unit in Gamma Knife surgery

Object

The authors sought to evaluate and improve the geometrical accuracy of a 3-tesla magnetic resonance (MR) imaging unit used for Gamma Knife surgery (GKS).

Methods

To evaluate the geometrical accuracy of a Siemens Magnetom Trio 3-tesla MR imaging unit, two phantoms were used. Both phantoms were imaged with computed tomography (CT), a 1.5-tesla MR imaging unit (Siemens Avanto), and the 3-tesla MR imaging unit. A pair of orthogonal films was obtained with a radiotherapy simulator to validate the spatial coordinates of the marker positions determined with CT. The coordinates of the markers were measured using the GammaPlan treatment planning software. Magnetic resonance imaing was performed using three-dimensional (3D) magnetization-prepared rapid acquisition gradient echo (MPRAGE) and fast low-angle shot sequence (FLASH) pulse sequences. The voxel size was 1 × 1 × 1 mm3.

Conclusions

The root-mean-square error of MR images was 2 ± 0.73 mm for 3D MPRAGE. The error was reduced to 1.5 ± 0.64 mm for FLASH. The errors were decreased further by applying an image distortion correction method (the field-of-view filter) to the images acquired with FLASH. The mean errors were 1.3 ± 0.39 mm and 1.5 ± 0.77 mm for the two phantoms. The errors increased from 1 mm to 3.1 mm as the measurement points approached the caudal edge of the head coil (larger z value). Proper selection of a pulse sequence together with a geometrical distortion correction improved the geometrical accuracy of MR images. However, further study is needed to increase the geometrical accuracy of 3-tesla MR imaging units for radiosurgical applications.

Long-Term Follow-Up of Trigeminal Neuralgia Treatment Using a Linear Accelerator

While most of the studies examining radiosurgery for trigeminal neuralgia have used a Gamma Knife, a linear accelerator can also be utilized for treatment. We report on 20 patients with trigeminal neuralgia who received 23 treatments with a linear accelerator that delivered a maximum dose of 82.3-100 Gy. The median patient follow-up was 56.5 months, 70% of patients had received previous surgical treatment and 20% had secondary (nonessential) trigeminal neuralgia. Eight (35%) radiosurgery treatments resulted in complete pain relief; 5 (63%) patients with initial pain relief had pain recurrence at a mean time of 21.5 months. Ten (43%) patients reported a 50% or more decrease in pain severity but have not achieved a pain-free state. A total of 18 (78%) treatments resulted in no pain or a 50% or greater improvement in pain. Five treatments (22%) resulted in less than 50% improvement in pain. We conclude that linear accelerator stereotactic radiosurgery is a viable treatment option for trigeminal neuralgia patients, especially for patients who have not had a previous invasive treatment.

Plane-parallel ionization chamber response in the buildup region of obliquely incident photon beams

Fixed-separation plane-parallel ionization chambers have been shown to overestimate the dose in the buildup region of normally incident high-energy photon beams. This work shows that these ionization chambers exhibit an even greater over-response in the buildup region of obliquely incident photon beams. This over-response at oblique incidence is greatest at the surface of the phantom and increases with increasing angle of beam incidence. In addition, the magnitude of the over-response depends on field size, beam energy, and chamber construction. This study shows that plane-parallel ionization chambers can over-respond by more than a factor of 2.3 at the phantom surface for obliquely incident high-energy photon fields.

Evaluation of eye shields made of tungsten and aluminum in high-energy electron beams

PURPOSE

To protect the lens and cornea of the eye when treating the eyelid with electrons, we designed a tungsten and aluminum eye shield that protected both the lens and cornea, and also limited the amount of backscatter to the overlying eyelid when using electron beam therapy.

METHODS AND MATERIALS

Custom curved tungsten eye shields, 2 mm and 3 mm thick, were placed on Kodak XV film on 8 cm polystyrene and irradiated to evaluate the transmission through the shields. To simulate the thickness of the eyelid and to hold the micro-TLDs, an aquaplast mold was made to match the curvature of the eye shields. Backscatter was measured by placing the micro-TLDs on the beam entrance side to check the dose to the underside of the eyelid. Measurements were done with no aluminum, 0.5, and 1.0 mm of aluminum on top of the tungsten eye shields. The measurements were repeated with 2- and 3-mm flat pieces of lead to determine both the transmission and the backscatter dose for this material.

RESULTS

Tungsten proved to be superior to lead for shielding the underlying structures and for reducing backscatter. At 6 MeV, a 3-mm flat slab of tungsten plus 0.5 mm of aluminum, resulted in .042 Gy under the shield when 1.00 Gy is delivered to dmax. At 6 MeV for a 3-mm lead plus 0.5-mm aluminum, .046 Gy was measured beneath the shield, a 9.5% decrease with the tungsten. Backscatter was also decreased from 1.17 to 1.13 Gy, a 4% decrease, when using tungsten plus 0.5 mm of aluminum vs. the same thickness of lead. Measurements using 9 MeV were performed in the same manner. With 3 mm tungsten and 0.5 mm of aluminum, at 3 mm depth the dose was .048 Gy compared to .079 Gy with lead and aluminum (39% decrease). Additionally, the backscatter dose was 3% less using tungsten. Simulating the lens dose 3 mm beyond the shield for the 2-mm and 3-mm custom curved tungsten eye shields plus 0.5 mm of aluminum was .030 and .024 Gy, respectively, using 6 MeV (20% decrease). Using 9-MeV electrons, the dose 3 mm beyond the shield was .048 Gy for the 2-mm shield and .029 Gy for the 3-mm shield (40% decrease). Backscatter was not further decreased using thicker tungsten. With a 6-MeV beam, using the 2-mm or 3-mm custom tungsten eye shields plus 0.5 mm of aluminum, the backscattered doses were 1.03 and 1.02 Gy, respectively. The backscatter dose with 9 MeV was 1.06 Gy using the 2-mm custom shield plus 0.5 mm aluminum and 1.05 Gy with a 3-mm custom shield plus 0.5 mm aluminum. There was very little difference in backscatter dosage under the eyelid using 0.5 vs. 1.0 mm of aluminum. Therefore, for patient comfort, we recommend using 0.5 mm of aluminum.

CONCLUSIONS

Tungsten is superior to lead as a material for eye shields due to its higher density and lower atomic number (Z). Using 6- and 9-MeV electrons, tungsten provides the necessary protection for the lens and cornea of the eye and decreases the amount of backscatter to the eyelid above the shield.

Stereotactic radiosurgery in pediatric patients

Although stereotactic radiosurgery has been studied extensively in adults, the data demonstrating its efficacy in children is limited. Medical records were reviewed to identify the indications for and outcomes of patients treated with this modality. Linear accelerator-based radiosurgery was used to treat 11 recurrent brain tumors and one posterior fossa arteriovenous malformation over 3 years. The mean and median age of those treated was 10 and 8 years, respectively (range 1-20 years). Patients received 700 to 3,000 cGy delivered to the 50-90% isodose line in a single fraction. The mean and median follow-up was 15 and 17 months, respectively. Three of the four children with malignant disease died 6 to 9 months after treatment. One patient died of recurrence outside the treatment field. Another child died of complications related to radiation injury, and the third died of disease progression. All children with low-grade tumors remain alive without complications. Six of eight (75%) children exhibit substantial radiographic reductions in tumor size. The child with a vascular malformation has been followed for 26 months, without hemorrhage and with a radiographically proved decrease in size. Our series suggests that radiosurgery has limited usefulness in malignant disease. Therapeutic response is influenced by lesion size and/or location. Stereotactic radiosurgery appears to be effective in children with low-grade intracranial tumors or arteriovenous malformations. Further experience is required to establish the role and long term side effects of radiosurgery in pediatric patients.

Evaluation of electronic portal imaging device for missing tissue compensator design and verification

The purpose of this investigation is to determine if electronic portal imaging devices (EPIDs) can be used for the design and verification of compensating filters. In order to do this, we investigated the operating characteristics of a commercially available EPID and the variation in transmitted dose for various measurement situations. We performed four initial tests to determine the EPID response specific to compensator situations. The tests determined EPID response to variable patient SSDs, different gantry angles, positions of an inhomogeneity within a phantom, and the sensitivity variation of different parts of the imager. After these tests, we determined the attenuation functions relating EPID response to phantom thickness for various phantom materials. With these functions, we tested simple compensation situations to demonstrate that missing tissue compensators can both be designed and verified using EPIDs.

Total skin electron arc irradiation using a reclined patient position

Several techniques for the treatment of the total skin of the patient using electron beams have been described in the literature. However, most techniques presuppose that the patient is capable of maintaining a standing position for the duration of the treatment. For patients either weakened by disease or those suffering from a loss of limbs, this is often an unrealistic expectation. We will describe a total skin electron irradiation technique that allows the patient to remain in a reclined position without sacrificing dose uniformity. This technique uses two symmetric +/- 48 degrees arc electron beams to provide a field uniformity of +/- 5% over a range of approximately 250 cm X 45 cm. Six patient positions are used to provide a uniform dose around the periphery of the patient. A description of the treatment technique along with details of the dosimetry are given.

Role of point A in the era of computerized dosimetry

Treatment prescriptions based on milligram-hours and point A doses were examined in light of the recommended dose and volume specification for intracavitary therapy proposed by the International Commission on Radiation Units and Measurements (ICRU). Because neither point A doses nor milligram-hours are to be included in dose reporting, it is necessary to translate the vast empirical experience with prescriptions based on these parameters into the ICRU schema. A total of 90 Fletcher-Suit radium applications were analyzed to explore relationships between point A doses, milligram-hours, and the ICRU guidelines. It was demonstrated that some definitions of point A can have essentially no utility within any dosimetric system, while others can lead to treatment prescriptions with some degree of correspondence to ICRU recommendations. Older dosimetric concepts must be retained while newer ones are being developed.